Streetbeat News

Revenues

RSKD

Riskified (NYSE:RSKD) reported Q2 2024 adjusted EPS of $0.04, beating the estimate of $0.03 by 33.33%. Sales were $78.730M, surpassing the $78.487M estimate and marking an 8.20% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:51 am

PFGC

The purchase price represents an adjusted EBITDA multiple of 9.9x, including $50M of run-rate synergies.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:49 am

ALL

IAK

KBWP

Allstate Corporation (NYSE:ALL) has agreed to sell its Employer Voluntary Benefits business to StanCorp Financial Group for $2 billion in cash. The sale is expected to generate a $600 million gain and increase deployable capital by $1.6 billion. However, Allstate's adjusted net income return on equity is projected to decrease by approximately 100 basis points. The deal is anticipated to close in the first half of 2025. Additionally, Allstate and StanCorp will form a product distribution partnership. Allstate's stock has gained over 60% in the last 12 months, and investors can gain exposure via Invesco KBW Property & Casualty Insurance ETF (NASDAQ:KBWP) and iShares U.S. Insurance ETF (NYSE:IAK).

Portfolio Pulse from Lekha Gupta

August 14, 2024 | 10:44 am

CAH

Cardinal Health has raised its fiscal year 2025 outlook for adjusted EPS to $7.55-$7.70 from the preliminary outlook of at least $7.50, surpassing the consensus of $7.53. The company provided detailed segment revenue and profit projections, along with other financial metrics including share repurchases and capital expenditures.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:38 am

CAH

Cardinal Health reported its Q4 2024 results, with adjusted EPS of $1.84 beating the estimate of $1.73, and sales of $59.867 billion surpassing the expected $58.636 billion.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:32 am

MGIC

Magic Software Enterprises has reiterated its FY24 revenue guidance of $540 million to $550 million, aligning closely with the $544.42 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:25 am

MGIC

Magic Software reported Q2 2024 adjusted EPS of $0.24, which was in line with expectations. The company also reported sales of $136.25 million, beating the estimate of $132.69 million.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:23 am

SFL

SFL Corp reported Q2 2024 GAAP EPS of $0.16, beating the estimate of $(0.01). Sales were $190.915 million, surpassing the $183.950 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:21 am

ELYM

Eliem Therapeutics reported a Q2 EPS of $(1.81), a significant decrease from $(0.19) year-over-year. The company has cash and cash equivalents of approximately $220 million, which is expected to fund operations into 2027.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:09 am

APLM

Apollomics reported a significant improvement in its H1 EPS, moving from $(2.55) to $(0.38) year-over-year. The company also has a cash balance of $25.9 million, which is expected to sustain operations until Q3 of 2025.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 10:08 am